New early breast cancer drug to be made available in Australia, New Zealand and Southeast Asia following license deal. A new breast cancer drug shown to reduce the risk of cancer recurrence will soon be made available in Australia, New Zealand, and throughout Southeast Asia, following a license deal between Specialised Therapeutics Asia (ST Asia) and U.S. biopharmaceutical…